Elevated Levels of Basic Fibroblast Growth Factor in the Urine of Clam Enterocystoplasty Patients
- 1 February 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (2) , 468-470
- https://doi.org/10.1016/s0022-5347(01)66420-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of CancersJNCI Journal of the National Cancer Institute, 1994
- Elevated Levels of the Angiogenic Peptide Basic Fibroblast Growth Factor in Urine of Bladder Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell linesJournal of Cellular Physiology, 1992
- Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesisJournal of Cellular Biochemistry, 1991
- Growth factors in development, transformation, and tumorigenesisCell, 1991
- Malignancies in Bladder Augmentations and Intestinal ConduitsJournal of Urology, 1990
- Assessment of the Malignant Potential of CystoplastyBritish Journal of Urology, 1989
- “Clam” Ileocystoplasty for the Treatment of Refractory Urge IncontinenceBritish Journal of Urology, 1985
- The Treatment of Adult Enuresis and Urge Incontinence by EnterocystoplastyBritish Journal of Urology, 1982
- Endothelial-cell proliferation in experimental tumoursBritish Journal of Cancer, 1982